Drugs / PICOPREP
PICOPREP
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | PREPOPIK | — | 2012-07-16 | fda.gov ↗ |
Trials 6 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT01928862 | Jun 2014 → Feb 2017 | — | Ferring Pharmaceuticals | Completed | No outcome recorded |
| Phase 34 trials | ||||||
| Phase 3 | NCT02239692 | Nov 2014 → Jun 2015 | — | Ferring Pharmaceuticals | Completed | No outcome recorded |
| Phase 3 | NCT01356407 | Jan → May 2011 | — | Ferring Pharmaceuticals | Completed | No outcome recorded |
| Phase 3 | NCT01073930 | May → Oct 2010 | — | Ferring Pharmaceuticals | Completed | No outcome recorded |
| Phase 3 | NCT01073943 | May → Oct 2010 | — | Ferring Pharmaceuticals | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT04474002 | Dec 2020 → Dec 2022 | — | Queen Elizabeth Hospital, Hong Kong | Completed | No outcome recorded |
Also used as a comparator or background therapy in 5 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT06652906 Comparator | Jun → Dec 2024 overdue | — | RenJi Hospital | Recruiting | No outcome recorded |
| Phase 32 trials | ||||||
| Phase 3 | NCT03562884 Comparator | Jul 2018 → Apr 2019 | — | Ipsen | Completed | No outcome recorded |
| Phase 3 | NCT02321462 Comparator | Mar → Dec 2015 | — | Ipsen | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT05436054 Comparator | Oct 2022 → Dec 2025 overdue | colonic disorder | Aalborg University Hospital | Recruiting | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT01978509 Comparator | Sep 2013 → Mar 2019 | — | Mayo Clinic | Terminated | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 11 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PicoPrep | “PicoPrep™” NCT01073930 ↗ |
| Known as | Fortrans | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02321462 ↗ |
| Known as | Polyethylene glycol electrolyte dispersion | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06652906 ↗ |
| Known as | Prepopik | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01978509 ↗ |
| Modality | Small molecule | “Active substances: An envelope Picoprep® contains 10 mg sodium picosulfate, 3,5 g magnesium oxide, and 12 g citric acid.” NCT05436054 ↗ |
| Route | Oral | “PicoPrep: 2-sachets for oral solution in two divided doses” NCT01073930 ↗ |